PubRank

J A Goldstein

Author PubWeight™ 160.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 1994 3.75
2 Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994 3.05
3 The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics 1996 3.02
4 Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther 2007 2.54
5 Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998 2.12
6 Biopsy-induced tricuspid regurgitation after cardiac transplantation. Ann Thorac Surg 1994 2.07
7 Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 1993 1.86
8 Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 2001 1.83
9 Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc 2001 1.81
10 Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest 1993 1.79
11 Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet 2000 1.68
12 Surgical management of temporomandibular joint ankylosis in the pediatric population. Plast Reconstr Surg 1993 1.60
13 Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics 1975 1.55
14 Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. Pharmacogenetics 2001 1.53
15 Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother 1988 1.46
16 Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. Chest 1992 1.44
17 Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther 2007 1.39
18 Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. Cathet Cardiovasc Diagn 1995 1.39
19 The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Clin Pharmacol Ther 1995 1.31
20 Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys 1998 1.28
21 Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab Dispos 2001 1.27
22 Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther 2001 1.26
23 Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol 1999 1.23
24 Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. J Pharmacol Exp Ther 1997 1.22
25 A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin. J Pharmacol Exp Ther 1998 1.21
26 Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation. Pharmacogenetics 1997 1.18
27 Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry 1991 1.18
28 Separation of pure polychlorinated biphenyl isomers into two types of inducers on the basis of induction of cytochrome P-450 or P-448. Chem Biol Interact 1977 1.16
29 One-stage anterior cervical decompression and posterior stabilization. A study of one hundred patients with a minimum of two years of follow-up. J Bone Joint Surg Am 1995 1.14
30 Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes. Biochem Pharmacol 1998 1.13
31 Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther 1995 1.13
32 Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am J Physiol Gastrointest Liver Physiol 2011 1.12
33 Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 2001 1.12
34 Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry 2001 1.11
35 Splicing defects in the COL3A1 gene: marked preference for 5' (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am J Hum Genet 1997 1.10
36 Fusion of liposomes containing a novel cationic lipid, N-[2,3-(dioleyloxy)propyl]-N,N,N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. Biochemistry 1989 1.09
37 Toothpick impaction with localized sigmoid perforation: successful colonoscopic management. Gastrointest Endosc 1999 1.09
38 An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. Pharmacogenetics 1998 1.09
39 Identification of the human P450 enzymes involved in lansoprazole metabolism. J Pharmacol Exp Ther 1996 1.08
40 The structure-activity relationships of halogenated biphenyls as enzyme inducers. Ann N Y Acad Sci 1979 1.08
41 Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Mol Pharmacol 1993 1.08
42 Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele. Pharmacogenetics 1999 1.08
43 The role of right ventricular systolic dysfunction and elevated intrapericardial pressure in the genesis of low output in experimental right ventricular infarction. Circulation 1982 1.08
44 A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. J Pharmacol Exp Ther 1999 1.05
45 Bioresorbable fixation for congenital pediatric craniofacial surgery: a 2-year follow-up. Pediatr Neurosurg 2000 1.03
46 Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin. J Pharmacol Exp Ther 1998 1.03
47 TRAM flap breast reconstruction and contralateral reduction or mastopexy. Plast Reconstr Surg 1993 1.03
48 Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. Blood Cells Mol Dis 2009 1.02
49 Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res 1992 1.02
50 Experimental hepatic porphyria induced by polychlorinated biphenyls. Toxicol Appl Pharmacol 1974 1.02
51 Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol 1997 1.02
52 Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. J Pharmacol Exp Ther 2001 1.01
53 2,3,7,8-Tetrachlorodibenzofuran in a commercially available 99% pure polychlorinated biphenyl isomer identified as the inducer of hepatic cytochrome P-448 and aryl hydrocarbon hydroxylase in the rat. Drug Metab Dispos 1978 1.01
54 Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 1993 1.01
55 Pseudo Sister Mary Joseph's nodule. Am J Gastroenterol 1999 1.00
56 Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos 1996 1.00
57 Complete hydatidiform mole with a coexistent healthy, viable fetus near term: a case report. J Reprod Med 1996 0.99
58 Volume loading improves low cardiac output in experimental right ventricular infarction. J Am Coll Cardiol 1983 0.97
59 Toxicological assessment of hexachlorobiphenyl isomers and 2,3,7,8,-tetrachlorodibenzofuran in chicks. II. Effects on drug metabolism and porphyrin accumulation. Toxicol Appl Pharmacol 1976 0.96
60 Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J Antimicrob Chemother 1991 0.96
61 Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cytochrome P-450 in extrahepatic versus hepatic tissues. Mol Pharmacol 1984 0.96
62 A multifamily study on the relationship between CYP2C19 genotype and s-mephenytoin oxidation phenotype. Pharmacogenetics 1995 0.96
63 Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19. Biochem Pharmacol 1999 0.95
64 Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms. Clin Cardiol 1998 0.94
65 Assessment of denaturing high-performance liquid chromatography (DHPLC) in screening for mutations in connexin 26 (GJB2). Hum Mutat 2001 0.94
66 The role of endoscopy in dyspepsia. Gastrointest Endosc 2001 0.93
67 Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. J Am Acad Dermatol 1982 0.93
68 Natural-Y Même polyurethane versus smooth silicone: analysis of the soft-tissue interaction from 3 days to 1 year in the rat animal model. Plast Reconstr Surg 1990 0.93
69 Limulus amebocyte lysate test in neonates. Am J Clin Pathol 1976 0.93
70 Does spinal instrumentation influence the healing process of posterolateral spinal fusion? An in vivo animal model. Spine (Phila Pa 1976) 1999 0.91
71 Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes. Pharmacogenetics 2000 0.91
72 Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. Biochem Biophys Res Commun 1993 0.90
73 Hepatic porphyria induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse. Res Commun Chem Pathol Pharmacol 1973 0.90
74 A comparative study of two polychlorinated biphenyl mixtures (Aroclors 1242 and 1016) containing 42% chlorine on induction of hepatic porphyria and drug metabolizing enzymes. Toxicol Appl Pharmacol 1975 0.90
75 Interaction of hexachlorobenzene with the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro and in vivo. Evidence that hexachlorobenzene is a weak Ah receptor agonist. Arch Biochem Biophys 1989 0.89
76 Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P-450. Essential role of cytochrome P-450d. Biochem J 1989 0.89
77 Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen. Arch Biochem Biophys 1998 0.89
78 Nonpenetrance in FGFR3-associated coronal synostosis syndrome. Am J Med Genet 1998 0.88
79 Increases in cytochrome P-450 mediated 17 beta-estradiol 2-hydroxylase activity in rat liver microsomes after both acute administration and subchronic administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a two-stage hepatocarcinogenesis model. Carcinogenesis 1988 0.88
80 Hemodynamic manifestations of ischemic right heart dysfunction. Cathet Cardiovasc Diagn 1992 0.88
81 Identification of human CYP2C19 residues that confer S-mephenytoin 4'-hydroxylation activity to CYP2C9. Biochemistry 2001 0.87
82 Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry 1995 0.87
83 Genetic polymorphism of S-mephenytoin 4'-hydroxylation in African-Americans. Pharmacogenetics 1996 0.87
84 Induction of porphyria in the rat by chronic versus acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol 1982 0.87
85 The efficacy of bioresorbable fixation in the repair of mandibular fractures: an animal study. J Oral Maxillofac Surg 2000 0.87
86 Isotretinoin in the treatment of acne: histologic changes, sebum production, and clinical observations. Arch Dermatol 1982 0.86
87 Impaired left atrial function after heart transplantation: disparate contribution of donor and recipient atrial components studied on-line with quantitative echocardiography. J Heart Lung Transplant 1995 0.85
88 Favorable prognosis for children with Pfeiffer syndrome types 2 and 3: implications for classification. Am J Med Genet 1998 0.84
89 Induction of cytochrome P-450 isozymes by hexachlorobenzene in rats and aromatic hydrocarbon (Ah)-responsive mice. J Biochem Toxicol 1986 0.84
90 The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol Appl Pharmacol 1991 0.84
91 Purification and characterization of a second form of hepatic cytochrome P-448 from rats treated with a pure polychlorinated biphenyl isomer. J Biol Chem 1982 0.84
92 Detection of fungi in the nasal mucosa using polymerase chain reaction. Laryngoscope 2001 0.84
93 Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Mol Pharmacol 1991 0.84
94 Isolation of a new canine cytochrome P450 CDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression. Drug Metab Dispos 1998 0.83
95 Cloning and expression of complementary DNAs for multiple members of the human cytochrome PH50IIC subfamily. Biochemistry 1993 0.83
96 Determinants of the recovery of right ventricular performance following experimental chronic right coronary artery occlusion. Circulation 1993 0.83
97 Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. Tubercle 1990 0.83
98 Failure of benzoyl peroxide to decrease sebaceous gland secretion in acne. Dermatologica 1981 0.83
99 Disordered drinking in developing spontaneously hypertensive rats. Am J Physiol 1985 0.82
100 Effects of a polybrominated biphenyl mixture in the rat and mouse. I. Six-month exposure. Toxicol Appl Pharmacol 1983 0.82
101 Solitary primary cutaneous CD30+ large cell lymphoma of natural killer cell phenotype bearing the t(2;5)(p23;q35) translocation and presenting in a child. Am J Dermatopathol 2000 0.82
102 Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy. Climacteric 2010 0.82
103 Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1. Mol Pharmacol 2012 0.82
104 Mycobacterium avium-intracellulare infection and possibly venereal transmission. Ann Intern Med 1984 0.82
105 Pharmacogenetics in clinical pharmacology and toxicology. Can J Physiol Pharmacol 1995 0.82
106 Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole activity. J Biol Chem 1996 0.82
107 Advantages of the postauricular coronal incision. Ann Plast Surg 1992 0.82
108 The chronic toxicity of technical and analytical pentachlorophenol in cattle. I. Clinicopathology. Toxicol Appl Pharmacol 1980 0.82
109 Diagnostic and therapeutic approach to pancreatic cancer. Biomed Pharmacother 2000 0.81
110 Orbital involvement of cervicofacial necrotizing fasciitis. Arch Ophthalmol 1995 0.81
111 Characterization of a cDNA for rat P-450g, a highly polymorphic, male-specific cytochrome in the P-450IIC subfamily. Biochemistry 1989 0.81
112 Enhanced biliary excretion of thyroxine glucuronide in rats pretreated with benzpyrene. Biochem Pharmacol 1968 0.81
113 Calcium channel blockers in the treatment of panic disorder. J Clin Psychiatry 1985 0.81
114 Suppression of the constitutive, male-specific rat hepatic cytochrome P-450 2c and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl and 3-methylcholanthrene. Mol Pharmacol 1987 0.81
115 Cytochrome P4501A1 mediates the metabolism of 2,3,7,8-tetrachlorodibenzofuran in the rat and human. Toxicol Appl Pharmacol 1993 0.81
116 Effects of pentachlorophenol on hepatic drug-metabolizing enzymes and porphyria related to contamination with chlorinated dibenzo-p-dioxins and dibenzofurans. Biochem Pharmacol 1977 0.81
117 Assessment of the contribution of chlorinated dibenzo-p-dioxins and dibenzofurans to hexachlorobenzene-induced toxicity, porphyria, changes in mixed function oxygenases, and histopathological changes. Toxicol Appl Pharmacol 1978 0.81
118 Reconstruction of skull defects in children and adolescents by the use of fixed cranial bone grafts: long-term results. Neurosurgery 1993 0.81
119 Induction of specific cytochrome P-450 isozymes by methylenedioxyphenyl compounds and antagonism by 3-methylcholanthrene. Arch Biochem Biophys 1985 0.80
120 The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice. Biochem J 1988 0.80
121 Emergent treatment of pelvic fractures. Comparison of methods for stabilization. Clin Orthop Relat Res 1995 0.80
122 Fetal tibial bone healing in utero: the effects of miniplate fixation. Plast Reconstr Surg 1993 0.79
123 Effects of reperfusion on ischemic right ventricular dysfunction. Disparate mechanisms of benefit related to duration of ischemia. Circulation 1994 0.79
124 Investigation of silicone oil and fumed silica in an adjuvant animal model. Plast Reconstr Surg 1997 0.79
125 What information do parents of newborns with cleft lip, palate, or both want to know? Cleft Palate Craniofac J 2001 0.79
126 Use of endoscopy in diarrheal illnesses. Gastrointest Endosc 2001 0.79
127 Hormonal regulation of male-specific rat hepatic cytochrome P-450g (P-450IIC13) by androgens and the pituitary. J Biol Chem 1989 0.79
128 Imaging of acute myocardial infarction in man with contrast-enhanced computed transmission tomography. Am Heart J 1984 0.79
129 Invasive aspergillosis: an unusual manifestation of AIDS. N Y State J Med 1988 0.79
130 Immunochemical evidence for two 3-methylcholanthrene-inducible forms of cytochrome P-448 in rat liver microsomes using a double-antibody radioimmunoassay procedure. Mol Pharmacol 1983 0.78
131 Differential metabolism of acetanilide versus ethoxycoumarin and benzo[a]pyrene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450. Arch Biochem Biophys 1983 0.78
132 Phenotypic differences in expression of cytochrome P-450g but not its mRNA in outbred male Sprague-Dawley rats. Arch Biochem Biophys 1987 0.78
133 Cloning of canine cytochrome P450 2E1 cDNA: identification and characterization of two variant alleles. Drug Metab Dispos 2000 0.78
134 Suppression of male-specific cytochrome P450 2c and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl in rat liver is not causally related to changes in serum testosterone. Arch Biochem Biophys 1989 0.78
135 Disposition of 2,3,7,8-tetrabromodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzo-p-dioxin in the rat: biliary excretion and induction of cytochromes CYP1A1 and CYP1A2. Toxicol Appl Pharmacol 1991 0.78
136 Analysis of the soft-tissue response to components used in the manufacture of breast implants: rat animal model. Plast Reconstr Surg 1991 0.78
137 Erectile function and naltrexone. Ann Intern Med 1986 0.78
138 Diagnostic approach to pancreatic cancer. Gastroenterol Clin North Am 1999 0.78
139 Effects of purified and technical piperonyl butoxide on drug-metabolizing enzymes and ultrastructure of rat liver. Toxicol Appl Pharmacol 1973 0.78
140 Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1. Carcinogenesis 1983 0.78
141 Fluorinated substrate analogues as stereochemical probes of enzymatic reaction mechanisms. Biochemistry 1978 0.78
142 Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450. Cancer Res 1984 0.78
143 A single amino acid mutation (Ser180----Cys) determines the polymorphism in cytochrome P450g (P4502C13) by altering protein stability. J Biol Chem 1992 0.77
144 CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. Mol Pharmacol 2000 0.77
145 Validation of precision-cut liver slices in dynamic organ culture as an in vitro model for studying CYP1A1 and CYP1A2 induction. Toxicol Appl Pharmacol 1996 0.77
146 Structure-activity relationships of chlorinated benzenes as inducers of different forms of cytochrome P-450 in rat liver. Chem Biol Interact 1982 0.77
147 Danazol and the rapid-cycling patient. J Clin Psychiatry 1986 0.77
148 Covalent binding to DNA and mutagenicity of 2,4-diaminotoluene metabolites produced by isolated hepatocytes and 9000 g supernatant from Fischer 344 rats. Carcinogenesis 1987 0.77
149 Molecular pathogenesis in sporadic head and neck paraganglioma. Laryngoscope 2000 0.77
150 Parotid saliva in cystic fibrosis. 1. Flow rate. Am J Dis Child 1965 0.77
151 Reduction mammoplasty with free-nipple transplantation: indications and technical refinements. Ann Plast Surg 1991 0.77
152 Deleterious effects of a systemic lytic state on reperfused myocardium. Minimization of reperfusion injury and enhanced recovery of myocardial function by direct angioplasty. Circulation 1995 0.77
153 Evaluation of left ventricular thrombi by contrast-enhanced computed tomography and two-dimensional echocardiography. Am J Cardiol 1986 0.77
154 CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population. Pharmacogenetics 1996 0.76
155 A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy. Blood Cells Mol Dis 2008 0.76
156 Possible therapy for snoring. West J Med 1983 0.75
157 Hydroxychloroquine for asthma. Am Rev Respir Dis 1983 0.75
158 The ineffectiveness of tobramycin combination therapy in Streptococcus faecium endocarditis. Yale J Biol Med 1984 0.75
159 A comparison of a commercial polybrominated biphenyl mixture, 2,4,5,2',4',5'-hexabromobiphenyl and 2,3,6,7-tetrabromonaphthalene as inducers of liver microsomal drug-metabolizing enzymes. Biochem Pharmacol 1979 0.75
160 Usefulness of adjunctive angioscopy and extraction atherectomy before stent implantation in high-risk aortocoronary saphenous vein grafts. Am J Cardiol 1995 0.75
161 Echocardiographic demonstration of outlet strut fracture of a Björk-Shiley mitral prosthesis. J Am Coll Cardiol 1986 0.75
162 The Russian [microorganisms] are coming. Recomb DNA Tech Bull 1982 0.75
163 From Pseudomonas to the birds: are animals patentable? Recomb DNA Tech Bull 1983 0.75
164 Carbamazepine treatment for stuttering. J Clin Psychiatry 1987 0.75
165 Characterization of a cDNA for the unexpressed form of cytochrome P-450g from the (-g) rat and differentiation of its mRNA from that of the (+g) phenotype using specific oligoprobes. Biochemistry 1990 0.75
166 Dose response for induction of two cytochrome P-450 isozymes and their mRNAs by 3,4,5,3'4'5'-hexachlorobiphenyl indicating coordinate regulation in rat liver. Mol Pharmacol 1985 0.75
167 Systemic absorption of clindamycin hydrochloride after topical application. J Am Acad Dermatol 1982 0.75
168 Fever, cough, anal ulcer in a heterosexual man. Hosp Pract (Off Ed) 1984 0.75
169 Rapid bedside coronary angiography with a portable fluoroscopic imaging system. Cathet Cardiovasc Diagn 1997 0.75
170 Merkel cell carcinoma of the cheek: a case report. J Oral Maxillofac Surg 1999 0.75
171 Marked differences in the inductive effects of two symmetrical hexachlorobiphenyls and the corresponding unsymmetrical isomer on hepatic monooxygenases. Biochem Pharmacol 1981 0.75
172 Maxillofacial considerations for diagnosis and treatment in Gorlin's syndrome: access osteotomies for cyst removal and orthognathic surgery. Ann Plast Surg 1994 0.75
173 Surgical correction of the Treacher Collins malar deficiency: quantitative CT scan analysis of long-term results. Plast Reconstr Surg 1993 0.75
174 Lithium treatment of central pain. J Clin Psychiatry 1985 0.75
175 [Lichen ruber planus treated with amphetamine shock]. Arch Argent Dermatol 1968 0.75
176 Clonidine as analgesic. Biol Psychiatry 1983 0.75
177 Multiple forms of solubilized and partially resolved cytochrome P-450 from rats induced by 2,3,5,2',3',5'- and 3,4,5,3',4',5'-hexachlorobiphenyls. Biochem Biophys Res Commun 1981 0.75
178 Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic and renal prostaglandin synthetase. Life Sci 1981 0.75
179 Diagnostic laparoscopy guidelines for clinical application. Gastrointest Endosc 2001 0.75
180 Refinements in pterygomaxillary dissociation for total midface osteotomies: instrumentation, technique, and CT scan analysis. Plast Reconstr Surg 1993 0.75
181 Infantile hemangioma of the accessory parotid gland. J Craniofac Surg 1998 0.75
182 Calcium and neurotransmission. Biol Psychiatry 1984 0.75
183 Malaria. A city hospital experience. Arch Intern Med 1988 0.75
184 Nifedipine treatment of Tourette's syndrome. J Clin Psychiatry 1984 0.75
185 Induction of cytochrome P-450c in hematopoietic cells of fetal liver. Biochem Biophys Res Commun 1986 0.75
186 Botox injection for achalasia: a modified technique. Gastrointest Endosc 1999 0.75
187 Melatonin as depression marker. Biol Psychiatry 1985 0.75
188 Effect of o-benzyl-p-chlorophenol on drug-metabolizing enzymes in rats. Biochem Pharmacol 1986 0.75
189 Cimetidine and mononucleosis. Ann Intern Med 1983 0.75
190 Treatment of chronic Epstein-Barr virus disease with H2 blockers. J Clin Psychiatry 1986 0.75
191 A footnote to the Cohen-Boyer patent and other musings. Recomb DNA Tech Bull 1982 0.75
192 Captopril in the treatment of psychogenic polydipsia. J Clin Psychiatry 1986 0.75
193 Methadone for depression. Biol Psychiatry 1984 0.75
194 Current status of global smallpox eradication. Am J Epidemiol 1971 0.75
195 Earring-induced localized iron tattoo. J Am Acad Dermatol 1991 0.75
196 Nonsteroidal anti-inflammatory drugs and panic disorder. J Clin Psychiatry 1986 0.75
197 Niacin and acute psychedelic psychosis. Biol Psychiatry 1984 0.75
198 Cimetidine, ranitidine, and Epstein-Barr virus infection. Ann Intern Med 1986 0.75
199 Curved biopsy forceps. Gastrointest Endosc 1998 0.75
200 Management of shock in acute myocardial infarction. Indian Heart J Teach Ser 1980 0.75
201 Investigation of doubling as a technique for involving severely withdrawn patients in group psychotherapy. J Consult Clin Psychol 1971 0.75
202 Induction of rat cytochrome P-450 3 and its mRNA by 3,4,5,3',4',5'-hexachlorobiphenyl. Mol Pharmacol 1988 0.75
203 Experimental hyperthermia in traumatic quadriplegia. Int J Biometeorol 1971 0.75
204 Protriptyline for snoring. N Engl J Med 1983 0.75
205 Successful stent implantation for acute myocardial infarction after failed thrombolytic therapy associated with massive hemorrhage. Cathet Cardiovasc Diagn 1996 0.75
206 Nitroglycerin therapy of asthma. Chest 1984 0.75
207 Genetic polymorphisms in human drug metabolic enzymes. Fundam Appl Toxicol 1997 0.75
208 Percutaneous vascular interventions in renal artery diseases. Minerva Cardioangiol 2006 0.75
209 Structure-activity relationships of chlorinated benzenes as inducers of hepatic cytochrome P-450 isozymes in the rat. IARC Sci Publ 1986 0.75
210 Alpha-2 agonists as analgesics. J Clin Psychiatry 1984 0.75